Stay updated on GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Sign up to get notified when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.

Latest updates to the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAn NIH-wide banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The page continues to show a 403 error instead of the study record.SummaryDifference1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check31 days agoChange DetectedAccess to the study record now results in a 403 Forbidden error, replacing the usual page content with a generic error message. The error page includes a Home link, indicating the study page is currently inaccessible rather than presenting the study details.SummaryDifference0.5%

- Check38 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating the study record is currently inaccessible; related documents and location details that were previously listed are no longer visible on the page.SummaryDifference18%

- Check45 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, indicating an internal version update to the page/template; this does not affect the study details presented to users.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision: v3.6.6 is now displayed on the page, replacing the previous v3.6.5. This reflects a platform release update rather than any changes to study details or participation data.SummaryDifference0.0%

Stay in the know with updates to GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.